Newsletter

    Investor Insights Archive

    Quarterly perspectives on healthcare transformation, Signal-Based Medicine advancement, and portfolio company updates from Veracor Capital.

    Subscribe to Future Editions

    Quarterly insights delivered to your inbox

    Past Editions

    December 2024

    Q4 2024: Signal-Based Medicine Momentum

    The healthcare paradigm shift accelerates as outcomes-based care gains institutional recognition. Plus: Kure Health Ecosystem Fund portfolio update and 2025 outlook.

    47,000+ patients healed milestone reached
    New partnerships in regenerative medicine
    2025 investment themes preview
    September 2024

    Q3 2024: Women in Healthcare Leadership

    Spotlight on women-led healthcare ventures outperforming traditional models. Women's Empowerment Fund thesis validation and Beau Luxe Beauty expansion.

    Women-led ventures 2.3x return multiple
    Beau Luxe Beauty market expansion
    New advisory board appointments
    June 2024

    Q2 2024: The Kure Health Ecosystem

    Deep dive into vertical integration advantages. How KureCare, Kure Health, and EliteMD create compounding value for investors.

    95% success rate clinical outcomes
    50-state operational infrastructure
    Telehealth platform enhancement
    March 2024

    Q1 2024: Why Healthcare, Why Now

    The $4.3 trillion healthcare opportunity explained. Market dynamics driving the shift from disease management to actual healing.

    Healthcare represents 18% of U.S. GDP
    Value-based care regulatory tailwinds
    Fund formation announcement

    Ready to Learn More?

    Schedule a consultation to discuss how Veracor Capital's healthcare investments align with your portfolio objectives.